JSA represented MO Alternate Investment Advisors on the deal. MO Alternate Investment Advisors, a subsidiary of the conglomerate Motilal Oswal Financial Services, executed an Investment in Join Ventures Solutions...
MO Alternate Investment Advisors’ Series B Investment Round
ArriVent Biopharma’s $155M Series B Financing
Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
Acquisition by IDI of a Stake in Omnes Capital Integrated into its New Management Company idiCo for Third-Party Management
Mayer Brown is advising IDI on its investment in Omnes Capital and the creation of the new third-party management company idiCo. IDI Group, a private equity...